
IndraLab
Statements
reach
"Thus, this positive association between CD44 and PD-L1 might provide the rationale for investigating the effect of monoclonal PD-L1/PD-1 antibodies administration on the CD44 expression and stemness of TNBC cells in affected patients.The current systematic review has several strengths."
sparser
"A study found that in TNBC and NSCLC, the cell surface adhesion receptor CD44 was a critical positive regulator of PD-L1; CD44 could bind to the regulatory region of PD-L1, which contains the CD44-ICD binding site and activates PD-L1 transcription through its ICD; the activated PD-L1 could promote tumor cell proliferation independent of T cell response ( xref )."